Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.33
USPH's Cash to Debt is ranked lower than
51% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 0.40 vs. USPH: 0.33 )
Ranked among companies with meaningful Cash to Debt only.
USPH' s Cash to Debt Range Over the Past 10 Years
Min: 0.24  Med: 0.77 Max: 298.04
Current: 0.33
0.24
298.04
Equity to Asset 0.54
USPH's Equity to Asset is ranked higher than
60% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. USPH: 0.54 )
Ranked among companies with meaningful Equity to Asset only.
USPH' s Equity to Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.69 Max: 0.85
Current: 0.54
0.31
0.85
Interest Coverage 46.18
USPH's Interest Coverage is ranked higher than
77% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 6.34 vs. USPH: 46.18 )
Ranked among companies with meaningful Interest Coverage only.
USPH' s Interest Coverage Range Over the Past 10 Years
Min: 42.07  Med: 69.97 Max: N/A
Current: 46.18
F-Score: 5
Z-Score: 5.63
M-Score: -2.82
WACC vs ROIC
8.78%
17.77%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 14.55
USPH's Operating margin (%) is ranked higher than
74% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 7.16 vs. USPH: 14.55 )
Ranked among companies with meaningful Operating margin (%) only.
USPH' s Operating margin (%) Range Over the Past 10 Years
Min: 12.72  Med: 14.48 Max: 15.71
Current: 14.55
12.72
15.71
Net-margin (%) 6.87
USPH's Net-margin (%) is ranked higher than
61% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 4.71 vs. USPH: 6.87 )
Ranked among companies with meaningful Net-margin (%) only.
USPH' s Net-margin (%) Range Over the Past 10 Years
Min: 4.66  Med: 6.29 Max: 8.85
Current: 6.87
4.66
8.85
ROE (%) 14.75
USPH's ROE (%) is ranked higher than
71% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 9.62 vs. USPH: 14.75 )
Ranked among companies with meaningful ROE (%) only.
USPH' s ROE (%) Range Over the Past 10 Years
Min: 10.36  Med: 14.33 Max: 19.88
Current: 14.75
10.36
19.88
ROA (%) 8.41
USPH's ROA (%) is ranked higher than
75% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 3.86 vs. USPH: 8.41 )
Ranked among companies with meaningful ROA (%) only.
USPH' s ROA (%) Range Over the Past 10 Years
Min: 6.43  Med: 9.79 Max: 13.79
Current: 8.41
6.43
13.79
ROC (Joel Greenblatt) (%) 124.04
USPH's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 18.36 vs. USPH: 124.04 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
USPH' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 45.91  Med: 118.29 Max: 149.88
Current: 124.04
45.91
149.88
Revenue Growth (3Y)(%) 8.10
USPH's Revenue Growth (3Y)(%) is ranked higher than
55% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 6.70 vs. USPH: 8.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
USPH' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 7.1  Med: 12.50 Max: 18.8
Current: 8.1
7.1
18.8
EBITDA Growth (3Y)(%) 7.20
USPH's EBITDA Growth (3Y)(%) is ranked higher than
53% of the 146 Companies
in the Global Medical Care industry.

( Industry Median: 6.60 vs. USPH: 7.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
USPH' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -0.2  Med: 13.60 Max: 27
Current: 7.2
-0.2
27
EPS Growth (3Y)(%) 5.40
USPH's EPS Growth (3Y)(%) is ranked lower than
54% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. USPH: 5.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
USPH' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -2.5  Med: 12.60 Max: 56.7
Current: 5.4
-2.5
56.7
» USPH's 10-Y Financials

Financials (Next Earnings Date: 2016-08-04)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

USPH Guru Trades in Q2 2015

Jim Simons 676,200 sh (-0.24%)
Chuck Royce 860,845 sh (-6.48%)
» More
Q3 2015

USPH Guru Trades in Q3 2015

Jim Simons 750,217 sh (+10.95%)
Chuck Royce 674,664 sh (-21.63%)
» More
Q4 2015

USPH Guru Trades in Q4 2015

Jim Simons 691,200 sh (-7.87%)
Chuck Royce 616,364 sh (-8.64%)
» More
Q1 2016

USPH Guru Trades in Q1 2016

Paul Tudor Jones 11,900 sh (New)
Jim Simons 638,100 sh (-7.68%)
Chuck Royce 321,025 sh (-47.92%)
» More
» Details

Insider Trades

Latest Guru Trades with USPH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:NAS:PAHC, NAS:SGRY, NAS:LHCG, NAS:PRSC, OTCPK:COLRF, NYSE:AAC, OTCPK:MFCSF, NAS:AFAM, NAS:HWAY, NYSE:ADPT, OTCPK:PIHLF, NYSE:QHC, NAS:ADUS, NAS:USMD, NYSE:CCM, NAS:BIOS, AMEX:HLTH, OTCPK:CMBGF, NYSE:CYH, OTCPK:FDNH » details
Traded in other countries:UPH.Germany,
US Physical Therapy Inc operates outpatient physical and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, and rehabilitation of injured workers among others.

US Physical Therapy Inc is incorporated in the state of Nevada in April 1992. The Company, together with its subsidiaries operates outpatient physical and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company operates 489 clinics in 42 states. Its clinics are concentrated in the states including: Tennessee, Texas, Michigan, Maryland, Washington, New Jersey, Wisconsin, Georgia, Arizona, Virginia, Indiana, Florida and Maine. It also managed 16 physical therapy practices for third parties, primarily physicians. U.S. Physical Therapy operates outpatient physical and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, and rehabilitation of injured workers among others. The Company provides services at its clinics on an outpatient basis. The Company generally charge for treatment on a per procedure basis. Medicare patients are charged based on prescribed time increments and Medicare billing standards. In addition, its clinics will developes individual maintenance and self-management exercise programs to be continued after treatment. It markets its therapy to physicians, including orthopedic surgeons, neurosurgeons, physiatrists, internal medicine physicians, podiatrists, occupational medicine physicians and general practitioners. The Company's operations are subject to federal and state laws.

Ratios

vs
industry
vs
history
P/E(ttm) 32.26
USPH's P/E(ttm) is ranked lower than
61% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 26.60 vs. USPH: 32.26 )
Ranked among companies with meaningful P/E(ttm) only.
USPH' s P/E(ttm) Range Over the Past 10 Years
Min: 8.91  Med: 20.18 Max: 34.38
Current: 32.26
8.91
34.38
Forward P/E 31.75
USPH's Forward P/E is ranked lower than
86% of the 87 Companies
in the Global Medical Care industry.

( Industry Median: 19.53 vs. USPH: 31.75 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 32.26
USPH's PE(NRI) is ranked lower than
59% of the 185 Companies
in the Global Medical Care industry.

( Industry Median: 26.14 vs. USPH: 32.26 )
Ranked among companies with meaningful PE(NRI) only.
USPH' s PE(NRI) Range Over the Past 10 Years
Min: 8.91  Med: 19.10 Max: 33.63
Current: 32.26
8.91
33.63
Price/Owner Earnings (ttm) 24.51
USPH's Price/Owner Earnings (ttm) is ranked higher than
55% of the 86 Companies
in the Global Medical Care industry.

( Industry Median: 26.90 vs. USPH: 24.51 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
USPH' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 5.5  Med: 20.46 Max: 60.43
Current: 24.51
5.5
60.43
P/B 4.48
USPH's P/B is ranked lower than
74% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. USPH: 4.48 )
Ranked among companies with meaningful P/B only.
USPH' s P/B Range Over the Past 10 Years
Min: 1.12  Med: 2.67 Max: 4.65
Current: 4.48
1.12
4.65
P/S 2.19
USPH's P/S is ranked lower than
62% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 1.64 vs. USPH: 2.19 )
Ranked among companies with meaningful P/S only.
USPH' s P/S Range Over the Past 10 Years
Min: 0.48  Med: 1.23 Max: 2.27
Current: 2.19
0.48
2.27
PFCF 16.13
USPH's PFCF is ranked higher than
63% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 22.00 vs. USPH: 16.13 )
Ranked among companies with meaningful PFCF only.
USPH' s PFCF Range Over the Past 10 Years
Min: 3.33  Med: 10.34 Max: 19.4
Current: 16.13
3.33
19.4
POCF 14.10
USPH's POCF is ranked higher than
52% of the 166 Companies
in the Global Medical Care industry.

( Industry Median: 14.40 vs. USPH: 14.10 )
Ranked among companies with meaningful POCF only.
USPH' s POCF Range Over the Past 10 Years
Min: 2.83  Med: 8.72 Max: 16.45
Current: 14.1
2.83
16.45
EV-to-EBIT 16.79
USPH's EV-to-EBIT is ranked higher than
55% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 18.68 vs. USPH: 16.79 )
Ranked among companies with meaningful EV-to-EBIT only.
USPH' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.9  Med: 8.70 Max: 17.2
Current: 16.79
3.9
17.2
EV-to-EBITDA 14.32
USPH's EV-to-EBITDA is ranked lower than
53% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 13.28 vs. USPH: 14.32 )
Ranked among companies with meaningful EV-to-EBITDA only.
USPH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.1  Med: 7.50 Max: 14.8
Current: 14.32
3.1
14.8
PEG 6.27
USPH's PEG is ranked lower than
81% of the 78 Companies
in the Global Medical Care industry.

( Industry Median: 2.70 vs. USPH: 6.27 )
Ranked among companies with meaningful PEG only.
USPH' s PEG Range Over the Past 10 Years
Min: 0.8  Med: 1.60 Max: 5.96
Current: 6.27
0.8
5.96
Shiller P/E 45.13
USPH's Shiller P/E is ranked lower than
80% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 28.62 vs. USPH: 45.13 )
Ranked among companies with meaningful Shiller P/E only.
USPH' s Shiller P/E Range Over the Past 10 Years
Min: 11.61  Med: 25.92 Max: 46.8
Current: 45.13
11.61
46.8
Current Ratio 2.81
USPH's Current Ratio is ranked higher than
85% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 1.36 vs. USPH: 2.81 )
Ranked among companies with meaningful Current Ratio only.
USPH' s Current Ratio Range Over the Past 10 Years
Min: 1.63  Med: 4.40 Max: 16.64
Current: 2.81
1.63
16.64
Quick Ratio 2.81
USPH's Quick Ratio is ranked higher than
87% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. USPH: 2.81 )
Ranked among companies with meaningful Quick Ratio only.
USPH' s Quick Ratio Range Over the Past 10 Years
Min: 1.63  Med: 4.40 Max: 16.64
Current: 2.81
1.63
16.64
Days Sales Outstanding 43.42
USPH's Days Sales Outstanding is ranked lower than
52% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 42.74 vs. USPH: 43.42 )
Ranked among companies with meaningful Days Sales Outstanding only.
USPH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.07  Med: 45.36 Max: 64.31
Current: 43.42
40.07
64.31
Days Payable 3.16
USPH's Days Payable is ranked lower than
96% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. USPH: 3.16 )
Ranked among companies with meaningful Days Payable only.
USPH' s Days Payable Range Over the Past 10 Years
Min: 2.36  Med: 3.28 Max: 5.88
Current: 3.16
2.36
5.88

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.07
USPH's Dividend Yield is ranked lower than
69% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 1.62 vs. USPH: 1.07 )
Ranked among companies with meaningful Dividend Yield only.
USPH' s Dividend Yield Range Over the Past 10 Years
Min: 0.31  Med: 1.25 Max: 1.74
Current: 1.07
0.31
1.74
Dividend Payout 0.33
USPH's Dividend Payout is ranked higher than
57% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 0.39 vs. USPH: 0.33 )
Ranked among companies with meaningful Dividend Payout only.
USPH' s Dividend Payout Range Over the Past 10 Years
Min: 0.16  Med: 0.26 Max: 0.44
Current: 0.33
0.16
0.44
Dividend Growth (3y) 18.60
USPH's Dividend Growth (3y) is ranked higher than
62% of the 71 Companies
in the Global Medical Care industry.

( Industry Median: 13.00 vs. USPH: 18.60 )
Ranked among companies with meaningful Dividend Growth (3y) only.
USPH' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 18.6
Current: 18.6
0
18.6
Forward Dividend Yield 1.13
USPH's Forward Dividend Yield is ranked lower than
67% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 1.67 vs. USPH: 1.13 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 1.05
USPH's Yield on cost (5-Year) is ranked lower than
79% of the 275 Companies
in the Global Medical Care industry.

( Industry Median: 2.24 vs. USPH: 1.05 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
USPH' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.31  Med: 1.25 Max: 1.74
Current: 1.05
0.31
1.74
3-Year Average Share Buyback Ratio -1.40
USPH's 3-Year Average Share Buyback Ratio is ranked higher than
59% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. USPH: -1.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
USPH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -9.8  Med: -0.50 Max: 7.7
Current: -1.4
-9.8
7.7

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.36
USPH's Price/Projected FCF is ranked higher than
63% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 1.65 vs. USPH: 1.36 )
Ranked among companies with meaningful Price/Projected FCF only.
USPH' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.38  Med: 0.92 Max: 3.08
Current: 1.36
0.38
3.08
Price/DCF (Earnings Based) 2.05
USPH's Price/DCF (Earnings Based) is ranked lower than
70% of the 30 Companies
in the Global Medical Care industry.

( Industry Median: 1.81 vs. USPH: 2.05 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.78
USPH's Price/Median PS Value is ranked lower than
88% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 1.07 vs. USPH: 1.78 )
Ranked among companies with meaningful Price/Median PS Value only.
USPH' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.47  Med: 1.02 Max: 2.45
Current: 1.78
0.47
2.45
Price/Peter Lynch Fair Value 5.45
USPH's Price/Peter Lynch Fair Value is ranked lower than
93% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 2.55 vs. USPH: 5.45 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
USPH' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.47  Med: 1.52 Max: 5.85
Current: 5.45
0.47
5.85
Earnings Yield (Greenblatt) (%) 5.97
USPH's Earnings Yield (Greenblatt) (%) is ranked higher than
64% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. USPH: 5.97 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
USPH' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 5.8  Med: 11.50 Max: 25.9
Current: 5.97
5.8
25.9
Forward Rate of Return (Yacktman) (%) 10.90
USPH's Forward Rate of Return (Yacktman) (%) is ranked higher than
52% of the 104 Companies
in the Global Medical Care industry.

( Industry Median: 10.57 vs. USPH: 10.90 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
USPH' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 10.8  Med: 19.60 Max: 29.2
Current: 10.9
10.8
29.2

More Statistics

Revenue (TTM) (Mil) $341.0
EPS (TTM) $ 1.86
Beta1.02
Short Percentage of Float4.22%
52-Week Range $42.59 - 63.41
Shares Outstanding (Mil)12.50

Analyst Estimate


Warning: Invalid argument supplied for foreach() in /home/gurufocu/public_html/modules/stock/estimate.php on line 163
Dec16 Dec17
Revenue (Mil $) 363 393
EPS ($) 1.89 2.15
EPS w/o NRI ($) 1.89 2.15
EPS Growth Rate
(3Y to 5Y Estimate)
15.00%
Dividends Per Share ($)
» More Articles for USPH

Headlines

Articles On GuruFocus.com
USPH: A Small Cap with Big Cap Predictability Oct 08 2014 
Four 'Boring' Stocks to Consider Sep 30 2014 
12 Healthcare Dividend Stocks with Gaining Earnings Momentum Apr 02 2012 
U.S. Physical Therapy Inc. (USPH) CEO Christopher J Reading sells 25,000 Shares Mar 11 2011 
U.S. Physical Therapy Inc. (USPH) COO Glenn Mcdowell sells 10,614 Shares Mar 11 2011 
U.S. Physical Therapy Inc. Reports Operating Results (10-K) Mar 10 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 5,000 Shares Mar 09 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 15,000 Shares Mar 04 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 5,000 Shares Dec 27 2010 
U.S. Physical Therapy Inc. Reports Operating Results (10-Q) Nov 04 2010 

More From Other Websites
USPh Schedules Second Quarter 2016 Earnings Release and Conference Call for Thursday August 4, 2016 Jul 07 2016
U.S. Physical Therapy, Inc. Schedules Second Quarter 2016 Earnings Release and Conference Call for... Jul 07 2016
Is US Physical Therapy an Incredible Momentum Stock? 3 Reasons Why USPH Will Be Tough to Beat Jun 29 2016
USPh to Present at the 2016 East Coast IDEAS Investor Conference Jun 23 2016
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 23 2016
U.S. Physical Therapy to Present at the 2016 East Coast IDEAS Investor Conference Jun 23 2016
ETF’s with exposure to U.S. Physical Therapy, Inc. : June 23, 2016 Jun 23 2016
U.S. Physical Therapy, Inc. :USPH-US: Earnings Analysis: Q1, 2016 By the Numbers : June 7, 2016 Jun 07 2016
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 03 2016
USPh to Present at the Citi's 2016 Small and Mid Cap Conference Jun 03 2016
USPh to Present at the Jefferies 2016 Global Healthcare Conference Jun 03 2016
U.S. Physical Therapy to Present at the Citi’s 2016 Small and Mid Cap Conference Jun 03 2016
U.S. Physical Therapy to Present at the Jefferies 2016 Global Healthcare Conference Jun 03 2016
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 18 2016
USPh to Present at the UBS Global Healthcare Conference May 18 2016
U.S. Physical Therapy to Present at the UBS Global Healthcare Conference May 18 2016
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 17 2016
U S PHYSICAL THERAPY INC /NV Financials May 14 2016
Can The Uptrend Continue for US Physical Therapy (USPH)? May 11 2016
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 09 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)